4.6 Review

Relative risk versus absolute risk: one cannot be interpreted without the other

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 32, 期 -, 页码 13-18

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfw465

关键词

absolute risk difference; epidemiology; number needed to treat; relative risk; risk reduction

向作者/读者索取更多资源

For the presentation of risk, both relative and absolute measures can be used. The relative risk is most often used, especially in studies showing the effects of a treatment. Relative risks have the appealing feature of summarizing two numbers (the risk in one group and the risk in the other) into one. However, this feature also represents their major weakness, that the underlying absolute risks are concealed and readers tend to overestimate the effect when it is presented in relative terms. In many situations, the absolute risk gives a better representation of the actual situation and also from the patient's point of view absolute risks often give more relevant information. In this article, we explain the concepts of both relative and absolute risk measures. Using examples from nephrology literature we illustrate that unless ratio measures are reported with the underlying absolute risks, readers cannot judge the clinical relevance of the effect. We therefore recommend to report both the relative risk and the absolute risk with their 95% confidence intervals, as together they provide a complete picture of the effect and its implications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Critical Care Medicine

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care

James C. Doidge, Doug W. Gould, Zia Sadique, Mark Borthwick, Robert A. Hatch, Fergus J. Caskey, Lui Forni, Robert F. Lawrence, Clare MacEwan, Marlies Ostermann, Paul R. Mouncey, David A. Harrison, Kathryn M. Rowan, J. Duncan Young, Peter J. Watkinson

Summary: This study evaluated the clinical and health economic impacts of transitioning from systemic heparin anticoagulation (SHA) to regional citrate anticoagulation (RCA) for continuous kidney replacement therapy (CKRT) in intensive care units (ICUs). The results showed that transition to RCA was not associated with changes in mortality, but was associated with increases in kidney support duration, advanced cardiovascular support duration, and ICU length of stay.

JOURNAL OF CRITICAL CARE (2023)

Article Medicine, Research & Experimental

Investigating strategies to improve AccesS to Kidney transplantation (the ASK trial): a protocol for a feasibility randomised controlled trial with parallel process evaluation

Pippa K. K. Bailey, Fergus J. J. Caskey, Stephanie MacNeill, Rachel Ashford, Lindsay Pryce, Liise Kayler, Yoav Ben-Shlomo

Summary: This study aims to improve access to living-donor kidney transplantation in the UK, with a focus on socioeconomically disadvantaged individuals. The study will evaluate the feasibility and acceptability of a multi-component intervention designed to increase opportunities for living kidney donation. Findings will inform the design of a future randomized controlled trial to assess the effectiveness of the intervention.

PILOT AND FEASIBILITY STUDIES (2023)

Review Urology & Nephrology

Complex Interventions Across Primary and Secondary Care to Optimize Population Kidney Health A Systematic Review and Realist Synthesis to Understand Contexts, Mechanisms, and Outcomes

Dominic M. Taylor, Ailish M. Nimmo, Fergus J. Caskey, Rachel Johnson, Maria Pippias, G. J. Melendez-Torres

Summary: Chronic kidney disease (CKD) affects 850 million people worldwide, but existing evidence-based treatments are underutilized and there is inequity in access to care. This study identified that interventions with automated detection, educational support, and specialist review can improve CKD care, but patient perspectives were lacking in available literature.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group

Emma O'Lone, Fred S. Apple, James O. Burton, Fergus J. Caskey, Jonathan C. Craig, Christopher R. deFilippi, Derek Forfang, Karen A. Hicks, Vivekanand Jha, Kenneth W. Mahaffey, Patrick B. Mark, Patrick Rossignol, Nicole Scholes-Robertson, Allison Jaue, Andrea K. Viecelli, Angela Y. Wang, David C. Wheele, David White, Wolfgang C. Winkelmayer, Charles A. Herzog

Summary: Cardiovascular disease is the leading cause of death in hemodialysis patients. However, there is currently no standardized definition of myocardial infarction (MI) for this population. The international working group recommends specific approaches for interpreting ischemic symptoms and performing baseline electrocardiograms to improve the accuracy of MI diagnosis in hemodialysis patients. While baseline cardiac troponin values are not recommended, serial cardiac biomarkers should be obtained when ischemia is suspected.

KIDNEY INTERNATIONAL (2023)

Article Urology & Nephrology

Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial

Simon J. Davies, David Coyle, Elizabeth J. Lindley, David Keane, John Belcher, Fergus J. Caskey, Indranil Dasgupta, Andrew Davenport, Ken Farrington, Sandip Mitra, Paula Ormandy, Martin Wilkie, Jamie MacDonald, Mandana Zanganeh, Lazaros Andronis, Ivonne Solis-Trapala, Julius Sim

Summary: Avoiding excessive dialysis-associated volume depletion may help preserve residual kidney function. A randomized controlled trial was conducted to examine whether knowledge of estimated normally hydrated weight could reduce the rate of loss of residual kidney function. The results showed that using a standardized clinical protocol for fluid assessment can effectively preserve residual kidney function without the need for bioimpedance measurements.

KIDNEY INTERNATIONAL (2023)

Article Transplantation

Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD

Nicholas C. Chesnaye, Fergus J. Caskey, Friedo W. Dekker, Esther N. M. de Rooi, Marie Evans, Olof Heimburger, Maria Pippias, Claudia Torino, Gaetana Porto, Maciej Szymczak, Christiane Drechsler, Christoph Wanner, Kitty J. Jager, Udo Bahner, Wolfgang Seeger, Adamasco Cupisti, Adelia Sagliocca, Alberto Ferraro, Alessandra Mele, Alessandro Naticchia, Alex Cosaro, Andrea Ranghino, Andrea Stucchi, Angelo Pignataro, Antonella De Blasio, Antonello Pani, Aris Tsalouichos, Bellasi Antonio, Biagio Raffaele Di Iorio, Butti Alessandra, Cataldo Abaterusso, Chiara Somma, Claudia D'alessandro, Claudia Torino, Claudia Zullo, Claudio Pozzi, Daniela Bergamo, Daniele Ciurlino, Daria Motta, Domenico Russo, Enrico Favaro, Federica Vigotti, Ferruccio Ansali, Ferruccio Conte, Francesca Cianciotta, Francesca Giacchino, Francesco Cappellaio, Francesco Pizzarelli, Gaetano Greco, Gaetana Porto, Giada Bigatti, Giancarlo Marinangeli, Gianfranca Cabiddu, Giordano Fumagalli, Giorgia Caloro, Giorgina Piccoli, Giovanbattista Capasso, Giovanni Gambaro, Giuliana Tognarelli, Giuseppe Bonforte, Giuseppe Conte, Giuseppe Toscano, Goffredo Del Rosso, Irene Capizzi, Ivano Baragetti, Lamberto Oldrizzi, Loreto Gesualdo, Luigi Biancone, Manuela Magnano, Marco Ricardi, Maria Di Bari, Maria Laudato, Maria Luisa Sirico, Martina Ferraresi, Michele Provenzano, Moreno Malaguti, Nicola Palmieri, Paola Murrone, Pietro Cirillo, Pietro Dattolo, Pina Acampora, Rita Nigro, Roberto Boero, Roberto Scarpioni, Rosa Sicoli, Rosella Malandra, Silvana Savoldi, Silvio Bertoli, Silvio Borrelli, Stefania Maxia, Stefano Maffei, Stefano Mangano, Teresa Cicchetti, Tiziana Rappa, Valentina Palazzo, Walter De Simone, Anita Schrander, Bastiaan van Dam, Carl Siegert, Carlo Gaillard, Charles Beerenhout, Cornelis Verburgh, Cynthia Janmaat, Ellen Hoogeveen, Ewout Hoorn, Friedo Dekker, Johannes Boots, Henk Boom, Jan-Willem Eijgenraam, Jeroen Kooman, Joris Rotmans, Kitty Jager, Liffert Vogt, Maarten Raasveld, Marc Vervloet, Marjolijn van Buren, Merel van Diepen, Nicholas Chesnaye, Paul Leurs, Pauline Voskamp, Peter Blankestijn, Sadie van Esch, Siska Boorsma, Stefan Berger, Constantijn Konings, Zeynep Aydin, Aleksandra Musiala, Anna Szymczak, Ewelina Olczyk, Hanna Augustyniak-Bartosik, Ilona Miskowiec-Wisniewska, Jacek Manitius, Joanna Pondel, Kamila Jedrzejak, Katarzyna Nowanska, Lukasz Nowak, Maciej Szymczak, Magdalena Durlik, Szyszkowska Dorota, Teresa Nieszporek, Zbigniew Heleniak, Andreas Jonsson, Anna-Lena Blom, Bjoern Rogland, Carin Wallquist, Denes Vargas, Emoeke Dimeny, Fredrik Sundelin, Fredrik Uhlin, Gunilla Welander, Isabel Bascaran Hernandez, Knut-Christian Groentoft, Maria Stendahl, Maria Svensson, Marie Evans, Olof Heimburger, Pavlos Kashioulis, Stefan Melander, Tora Almquist, Ulrika Jensen, Alistair Woodman, Anna McKeever, Asad Ullah, Barbara McLaren, Camille Harron, Carla Barrett, Charlotte O'Toole, Christina Summersgill, Colin Geddes, Deborah Glowski, Deborah McGlynn, Dympna Sands, Fergus Caskey, Geena Roy, Gillian Hirst, Hayley King, Helen McNally, Houda Masri-Senghor, Hugh Murtagh, Hugh Rayner, Jane Turner, Joanne Wilcox, Jocelyn Berdeprado, Jonathan Wong, Joyce Banda, Kirsteen Jones, Lesley Haydock, Lily Wilkinson, Margaret Carmody, Maria Weetman, Martin Joinson, Mary Dutton, Michael Matthews, Neal Morgan, Nina Bleakley, Paul Cockwell, Paul Roderick, Phil Mason, Philip Kalra, Rincy Sajith, Sally Chapman, Santee Navjee, Sarah Crosbie, Sharon Brown, Sheila Tickle, Suresh Mathavakkannan, Ying Kuan

Summary: This study explores the longitudinal trajectories of clinical indicators, patient-reported outcomes, and hospitalizations in older patients with advanced chronic kidney disease (CKD) before death. The results show that eGFR, Subjective Global Assessment score, and blood pressure decline, with accelerations observed 6 months before death. Serum hemoglobin, hematocrit, cholesterol, calcium, albumin, and sodium values decline slowly during follow-up, but with accelerations observed between 6 and 12 months before death. Physical and mental quality of life decline linearly, while the number of reported symptoms remains stable up to 2 years before death, accelerating at 1 year before death. The rate of hospitalization remains stable at around one hospitalization per person year, but increases exponentially 6 months before death.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Transplantation

Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study

Lorenza Magagnoli, Mario Cozzolino, Fergus J. Caskey, Marie Evans, Claudia Torino, Gaetana Porto, Maciej Szymczak, Magdalena Krajewska, Christiane Drechsler, Peter Stenvinkel, Maria Pippias, Friedo W. Dekker, Esther N. M. de Rooij, Christoph Wanner, Nicholas C. Chesnaye, Kitty J. Jager

Summary: Chronic kidney disease-mineral and bone disorder (CKD-MBD) is common in older non-dialysis patients with advanced CKD. PTH and phosphate are independently associated with all-cause mortality, while only PTH is associated with cardiovascular mortality. Calcium does not have an independent association with mortality but modifies the effect of phosphate.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Multidisciplinary Sciences

Predicting mortality after start of long-term dialysis-International validation of one- and two-year prediction models

Mikko Haapio, Merel van Diepen, Retha Steenkamp, Jaakko Helve, Friedo W. Dekker, Fergus Caskey, Patrik Finne

Summary: Mortality prediction is crucial in long-term kidney replacement therapy (KRT) for treatment decisions and resource planning. Existing models have mostly been internally validated, but this study externally validated the performance of two previously constructed models in the Dutch and UK KRT populations. The models showed good performance and encourage widespread implementation in European KRT populations.

PLOS ONE (2023)

Letter Urology & Nephrology

Psychological Health in Young Adults With Kidney Failure: A 5-Year Follow-up of the SPEAK Study

Mohammed Al-Talib, Fergus J. Caskey, Carol Inward, Yoav Ben-Shlomo, Alexander J. Hamilton

KIDNEY MEDICINE (2023)

Article Urology & Nephrology

Management and outcomes of myocardial infarction in people with impaired kidney function in England

Jemima Scott, Patrick Bidulka, Dominic M. Taylor, Udaya Udayaraj, Fergus J. Caskey, Kate Birnie, John Deanfield, Mark de Belder, Spiros Denaxas, Clive Weston, David Adlam, Dorothea Nitsch

Summary: In England, patients with impaired kidney function are less likely to receive invasive management compared to those with preserved kidney function. However, disparities in care may be decreasing over time, with the least difference seen in patients with STEMI managed via the primary percutaneous coronary intervention pathway. Impaired kidney function continues to be associated with worse outcomes after AMI.

BMC NEPHROLOGY (2023)

Editorial Material Urology & Nephrology

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine

Carmine Zoccali, Vianda Stel, Friedo Dekker, Kitty J. Jager

CLINICAL KIDNEY JOURNAL (2023)

Review Urology & Nephrology

The long-term benefits of early intensive therapy in chronic diseases-the legacy effect

Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Edouard L. Fu, Vianda S. Stel, Friedo W. Dekker, Kitty J. Jager

Summary: The 'legacy effect' describes the long-term benefits of intensive therapy in reducing complications and mortality in chronic diseases. It is evident in studies related to chronic kidney disease (CKD) and highlights the importance of intensive treatment. However, the legacy effect is more pronounced in early-stage diabetes and less evident in long-term, established diabetes patients.

CLINICAL KIDNEY JOURNAL (2023)

Article Health Care Sciences & Services

CareKnowDo-A Multichannel Digital and Telephone Support Program for People With Chronic Kidney Disease: Feasibility Randomized Controlled Trial

Riley Elizabeth Reston, Fergus J. Caskey, Barnaby Hole, Udaya Udayaraj, John Weinman

Summary: This study aimed to evaluate the feasibility of a digital self-management support and adherence program integrated with a patient-facing electronic health record. The findings suggest that the tailored digital and nurse call-based program is feasible and acceptable for patients with CKD.

JMIR FORMATIVE RESEARCH (2023)

Article Urology & Nephrology

Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial

Neeru Agarwal, Karan K. Shah, Kathryn Dansie, Paul N. Bennett, Lavern Greenham, Chris Brown, Brendan Smyth, Stephen McDonald, Shilpanjali Jesudason, Andrea K. Viecelli, Rachael L. Morton

Summary: This pilot study aimed to evaluate the feasibility of using electronic patient reported outcome measures (e-PROMs) to improve symptom control and treatment outcomes in hemodialysis patients. The results showed that electronic symptom monitoring with feedback to clinicians is feasible. However, there were variations in response and retention rates, potentially due to the lengthier questionnaire and higher frequency of data collection for the intervention arm.

BMC NEPHROLOGY (2023)

Review Urology & Nephrology

Differences in the epidemiology, management and outcomes of kidney disease in men and women

Nicholas C. Chesnaye, Juan Jesus Carrero, Manfred Hecking, Kitty J. Jager

Summary: Improved understanding of gender differences in kidney disease epidemiology, management, and outcomes is crucial to provide better care to patients. Women have a higher prevalence of early-stage chronic kidney disease, while men have a higher risk of kidney function decline, kidney failure, and cardiovascular disease. However, the protective effect of female sex diminishes with disease progression. Women are less likely to be diagnosed and treated for kidney disease and have lower health-related quality of life. They face more barriers to access the transplant waiting list but have better survival after transplantation.

NATURE REVIEWS NEPHROLOGY (2023)

暂无数据